Emmaus Life Sciences, Inc. (EMMA)
EMMA Stock Price Chart
Explore Emmaus Life Sciences, Inc. interactive price chart. Choose custom timeframes to analyze EMMA price movements and trends.
EMMA Company Profile
Discover essential business fundamentals and corporate details for Emmaus Life Sciences, Inc. (EMMA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 May 2000
Employees
34.00
Website
https://www.emmausmedical.comCEO
Willis C. Lee
Description
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California.
EMMA Financial Timeline
Browse a chronological timeline of Emmaus Life Sciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Apr 2026
Upcoming earnings on 17 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at -$0.02 , while revenue for the quarter reached $2.82M .
Earnings released on 15 May 2025
EPS came in at -$0.04 , while revenue for the quarter reached $2.41M .
Earnings released on 14 Apr 2025
EPS came in at -$0.03 falling short of the estimated $0.01 by -373.70%, while revenue for the quarter reached $3.29M , missing expectations by -45.13%.
Earnings released on 19 Nov 2024
EPS came in at -$0.01 falling short of the estimated $0.01 by -200.00%, while revenue for the quarter reached $5.48M , beating expectations by +9.56%.
Earnings released on 10 Sept 2024
EPS came in at -$0.07 falling short of the estimated $0.01 by -800.00%, while revenue for the quarter reached $5.38M , missing expectations by -23.19%.
Earnings released on 2 Jul 2024
EPS came in at $0.02 falling short of the estimated $0.03 by -33.33%, while revenue for the quarter reached $7.07M , beating expectations by +0.96%.
Earnings released on 30 Apr 2024
EPS came in at -$0.01 falling short of the estimated -$0.00 by -200.30%, while revenue for the quarter reached $2.51M , missing expectations by -49.88%.
Earnings released on 13 Nov 2023
EPS came in at -$0.01 surpassing the estimated -$0.04 by +75.00%, while revenue for the quarter reached $5.02M , beating expectations by +0.36%.
Earnings released on 14 Aug 2023
EPS came in at -$0.03 matching the estimated -$0.03, while revenue for the quarter reached $10.76M , beating expectations by +115.18%.
Earnings released on 15 May 2023
EPS came in at -$0.07 falling short of the estimated -$0.03 by -133.33%, while revenue for the quarter reached $6.75M , beating expectations by +35.06%.
Earnings released on 31 Mar 2023
EPS came in at $0.01 falling short of the estimated $0.16 by -93.75%, while revenue for the quarter reached $5.93M , missing expectations by -15.29%.
Earnings released on 14 Nov 2022
EPS came in at -$0.01 falling short of the estimated -$0.00 by -200.30%, while revenue for the quarter reached $4.94M , missing expectations by -17.68%.
Earnings released on 15 Aug 2022
EPS came in at -$0.18 falling short of the estimated -$0.01 by -1.90K%, while revenue for the quarter reached $4.29M , missing expectations by -28.55%.
Earnings released on 13 May 2022
EPS came in at -$0.03 falling short of the estimated -$0.01 by -400.00%, while revenue for the quarter reached $3.23M , missing expectations by -46.10%.
Earnings released on 31 Mar 2022
EPS came in at -$0.14 falling short of the estimated $0.05 by -380.00%, while revenue for the quarter reached $3.02M , missing expectations by -54.46%.
Earnings released on 12 Nov 2021
EPS came in at -$0.06 , while revenue for the quarter reached $5.77M .
Earnings released on 2 Sept 2021
EPS came in at $0.05 , while revenue for the quarter reached $6.49M .
Earnings released on 1 Sept 2021
EPS came in at -$0.17 , while revenue for the quarter reached $5.34M .
Earnings released on 26 Aug 2021
EPS came in at -$0.19 , while revenue for the quarter reached $4.36M .
Earnings released on 26 Aug 2021
EPS came in at $0.11 , while revenue for the quarter reached $6.95M .
Earnings released on 24 Aug 2021
EPS came in at $0.11 , while revenue for the quarter reached $5.60M .
Earnings released on 4 May 2021
EPS came in at -$0.01 , while revenue for the quarter reached $6.25M .
Earnings released on 25 Jan 2021
EPS came in at $0.09 , while revenue for the quarter reached $5.49M .
EMMA Stock Performance
Access detailed EMMA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.